Russell J. Cox, EVP & Chief Commercial Officer at Jazz Pharmaceuticals plc (JAZZ), sold 5,000 shares at $57.24 ($286K) on 2012-10-01, disclosed to the SEC on 2012-10-03.
Scheduled sale ($286k) by EVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2017-01-19 | $515K | — | Filing → |
| JAZZ | SELL | 2016-08-10 | $595K | — | Filing → |
| JAZZ | SELL | 2016-04-13 | $548K | — | Filing → |